A HANC Risk Stratification Score for Antiplatelet Therapy Optimization with Low-Dose Prasugrel in Taiwanese Acute Coronary Syndrome Patients from the Switch Study
Journal
Acta Cardiologica Sinica
Journal Volume
38
Journal Issue
6
Pages
751-764
Date Issued
2022-11
Author(s)
Lee, Wen-Lieng
Su, Chieh-Shou
Lee, Hsin-Fu
Tung, Ying-Chang
Liu, Ping-Yen
Su, Cheng-Huang
Kuo, Feng-Yu
Lin, Wei-Shiang
Chu, Pao-Hsien
Lu, Tse-Min
Lo, Ping-Han
Tsukiyama, Shuji
Yang, Wei-Chen
Cheng, Li-Chung
Yin, Wei-Hsian
Abstract
A significant proportion of acute coronary syndrome (ACS) patients experience high on-treatment platelet reactivity (HPR) on clopidogrel-based dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI).
Subjects
Acute coronary syndrome; CYP2C19; Clopidogrel; Dual anti-platelet therapy; East Asian paradox; High on-treatment platelet reactivity; Prasugrel; Risk stratification
SDGs
Publisher
TAIWAN SOC CARDIOLOGY
Type
journal article